Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Trefoil peptides are a growing group of proteins with interesting structural and functional properties. We have defined the pattern of trefoil peptide gene expression in the ulceration-associated cell lineage (UACL) and in the nearby mucosa in Crohn's disease. In the UACL, human
spasmolytic polypeptide
(hSP) mRNA is expressed in the acinar and proximal duct cells, while
pS2
mRNA and peptide are found in the distal duct cells and in the surface cells. In adjacent mucosa,
pS2
mRNA and protein are expressed by goblet cells, with the
pS2
peptide concentrated in the area of the Golgi and also in the theca. Ultrastructural immunolocalisation showed the
pS2
to be co-packaged in the mucous cell granules before being secreted into the intestinal lumen. In addition,
pS2
peptide was demonstrated in local neuroendocrine cells and was also co-packaged with the neuroendocrine granules. The crypts associated with the UACL also showed marked neuroendocrine cell hyperplasia. We conclude that
pS2
peptide is secreted locally into the viscoelastic coat covering the intestinal mucosa which surrounds Crohn's disease ulcers. In addition, it is clear that intestinal goblet cells, in addition to producing mucins, are a rich source of regulatory peptides. Moreover,
pS2
is clearly co-packaged with neurosecretory granules, which are released through basal and lateral membranes so that the contained peptides can act in a paracrine manner. These findings are interpreted in terms of the epidermal growth factor/urogastrone released by the UACL, stimulating
pS2
gene expression in surrounding cells.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. 129 63
There are many avenues where molecular biology is important in studying the gut, and here we explore methods for defining expression of a new gene family in the gut. We have defined the pattern of trefoil peptide gene expression in the ulceration-associated cell lineage (UACL) and in the nearby mucosa in Crohn's disease. In the UACL, human
spasmolytic polypeptide
mRNA and peptide are expressed in the acinar and proximal duct cells, whereas
pS2
mRNA and peptide are found in the distal duct cells and in the surface cells. In adjacent mucosa,
pS2
mRNA and protein are expressed ectopically by goblet cells. Ultrastructural immunolocalisation showed the
pS2
to be co-packaged in the mucous cell granules.
pS2
peptide was demonstrated in local neuroendocrine cells and was also co-packaged with the neuroendocrine granules. The crypts associated with the UACL also showed marked neuroendocrine cell hyperplasia. We have also cloned the newest trefoil peptide intestinal trefoil factor from human and rat intestinal mucosa and shown its co-expression with mucus by normal intestinal goblet cells. The co-packaging of the same secretory protein in both mucous and neuroendocrine granules, which have different functions, is unusual and indicates an important role for
pS2
in the secretory process itself or as a ligand delivered to its receptor via multiple routes. We conclude that the trefoil peptides are widely distributed in the intestine in inflammatory bowel disease and are of considerable potential functional importance.
...
PMID:Trefoil peptide expression in intestinal adaptation and renewal. 143 65
The human spasmolytic protein,
SML1
/hSP, an inhibitor of spasmolytic activity and gastric acid secretion in the pig, has been shown to exhibit homology to the
pS2 protein
, an estrogen-dependent breast cancer marker. Moreover,
SML1
/hSP and
pS2
are expressed at the same localization in the normal stomach and during healing of the gastrointestinal tract. Here we report the chromosomal localization, obtained by in situ hybridization, of the hSP gene (
SML1
) to chromosome 21 at 21q22.3. Using pulsed-field gel electrophoresis, we found
SML1
to be within 230 kb of the
BCEI
/
pS2
gene.
...
PMID:The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q 22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2. 150 66
A human cDNA corresponding to the porcine pancreatic spasmolytic protein (PSP) was isolated, and the recombinant clone was originally termed hSP for human spasmolytic protein. Later, the term
SML1
for
spasmolysin
was suggested for the human gene. This protein shows a remarkable sequence homology to
pS2
, a protein coded by an estrogen-induced gene isolated from the breast carcinoma cell line MCF-7. Although, at the DNA level, the gene sequences
pS2
and hSP/
SML1
display insufficient homology for cross-hybridization, their expression in tumor cells occurs with remarkable coordination. The human
pS2
gene sequence has been assigned to chromosome 21, and we have therefore attempted to map the hSP/
SML1
gene by using cDNA and Southern blotting of genomic DNAs from a panel of human-rodent somatic cell hybrids carrying different complements of human chromosomes. Interestingly, the hSP/
SML1
gene is also localized on chromosome 21.
...
PMID:Assignment of the gene for human spasmolytic protein (hSP/SML1) to chromosome 21. 151 87
The human
pS2
gene, isolated from the breast carcinoma cell line MCF-7 and shown to be under estrogen transcriptional control in a subclass of breast cancer cells was reported to be secreted in normal stomach surface epithelial cells, whereas additional gastrointestinal tissues like pancreas and colon do not secrete
pS2
at all. In porcine pancreas, a
spasmolytic polypeptide
(sharing domains of homology with
pS2
) was observed; a corresponding human gene (hSP) was shown to be active in normal stomach mucosa. hSP and
pS2
gene activity in normal and neoplastic pancreas tissues was then compared. Whereas both genes are inactive in normal pancreatic cells, activation of the
pS2
sequence in a primary pancreatic carcinoma cell culture and in 23 tumor tissues was noted when investigated by immunostaining. In all cases when
pS2
showed a regular 0.6 kb transcript, hSP displayed a transcript of 0.7 kb. Six of these tumors showed a reduced
pS2
immunoreactivity and, at the same time, aberrant
pS2
mRNA bands and a complete shut-down of the hSP gene were noted. In one case, whereas normal pancreas remained negative, the corresponding tumor and its metastasis displayed regular transcripts of
pS2
and hSP. This remarkably high correlation suggests that
pS2
and hSP expression in the pancreatic tumors, but not in their corresponding healthy tissue is significantly linked to molecular steps leading to tumorigenesis.
...
PMID:Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. 173 55
Recently, homology has been reported for
pS2
, a protein expressed in many human breast cancers, and a hormonogastric protein known as pancreatic
spasmolytic polypeptide
(SPP; formerly designated as PSP). The breast cancer estrogen inducible locus (BCEI), which encodes
pS2
, maps to human chromosome 21 (HSA 21). The SPP locus has not been mapped in humans. Several loci from HSA 21 have been mapped in cattle to syntenic group U10, but a BCEI bovine homolog was not detected. If a bovine BCEI locus does exist, map comparisons predict BCEI will reside on syntenic group U10. The assignment of bovine SPP to syntenic group U10 supports the postulated evolutionary relationship between BCEI and SPP.
...
PMID:The bovine pancreatic spasmolytic polypeptide gene maps to syntenic group U10: implications for the evolution of the human breast cancer estrogen inducible locus. 179 1
Expression of the pancreatic
spasmolytic peptide
(hSP) gene and
pS2
(a gene isolated from oestrogen-induced breast carcinoma cells) were analysed in 36 samples of human stomach carcinoma. 17 tumours were investigated at the RNA level (by northern blots) as well as at the gene product level (by immunochemistry). Since
pS2
had been shown to be expressed in normal stomach mucosa its activity in carcinoma samples was expected. Surprisingly, strong
pS2
immunoreactivity was noted in the diffuse carcinoma type, whereas the intestinal type displayed weak reactivity. The tumour samples showing strong immunostaining expressed the regular 0.6 kb
pS2
RNA band and weak staining was paralleled by aberrant transcripts. Additionally, only in tumour samples with regular
pS2
transcription was the typical 0.7 kb hSP RNA band seen; samples with aberrant
pS2
bands did not express hSP at all. This is the first demonstration of hSP gene activity in a human tumour.
...
PMID:Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. 182 22
Expression of
pS2
(an estrogen-induced gene isolated from breast carcinoma MCF7 cells) and of the human
spasmolytic peptide
(hSP) gene was analyzed in 21 human biliary tract and gallbladder carcinomas and 16 non-neoplastic gallbladders at the protein level (immunochemistry) and, in a series of these cases, at the RNA level (Northern blots). Eighteen carcinomas and 14 non-neoplastic mucosae with inflammatory alterations showed
pS2
activity by immunostaining or Northern blotting. In addition, in samples with
pS2
expression, hSP RNA was demonstrated. In the corresponding non-neoplastic and healthy mucosae,
pS2
was negative, as judged by immunostaining. Northern blots showed weak (basal) level of activity for
pS2
and hSP. The genes' increased expression in correlation to inflammatory and neoplastic processes, by now observed in several carcinomas and idiopathic inflammatory bowel disease, hints to their essential role in such diseases.
...
PMID:Breast cancer-associated protein pS2 expression in tumors of the biliary tract. 192 43
The
pS2
gene encodes for a small cysteine-rich protein, and was originally found by differential screening of a cDNA library from the human breast carcinoma cell line, MCF-7. The presence of
pS2
is closely correlated with oestrogen dependence in breast carcinomas. While the function of
pS2
is unknown,
pS2 protein
has been shown to be homologous with the gastrointestinal peptide hormone pancreatic
spasmolytic polypeptide
(PSP) and its human counterpart hSP, in which a 5-cysteine domain is tandemly repeated. The 5' flanking region of the
pS2
gene contains an enhancer region responsive to oestrogens and to epidermal growth factor (EGF/URO). We now report that
pS2
and hSP expression occurs in a wide range of endodermally-derived tissues, including the duodenum, the pancreas, and in a recently defined cell lineage associated with chronic gastrointestinal ulceration. In each case, this expression was associated with secretion of immunoreactive EGF/URO. We further show that the co-expression of
pS2
and hSP in gastric surface epithelial cells is also associated with the secretion of EGF/URO in the subjacent mucous neck cells. Our results indicate that local EGF/URO secretion induces
pS2
and hSP in adjacent cells, and that these molecules are then available to participate in pathophysiological responses. The finding of similar patterns of EGF/URO, hSP and
pS2
expression in association with chronic damage suggests that this is a fundamental response in the healing of these tissues.
...
PMID:Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. 229 Jan 13
Mature dermal glands of Xenopus laevis contain storage granules with a characteristic ellipsoid shape. These granules contain, as a minor component, a heat-stable, acidic polypeptide with an apparent molecular mass of 75 kDa. Using antibodies against this protein, positive clones were isolated from a cDNA expression library prepared from skin of X. laevis. One of the cloned cDNAs encodes a pre-protein with a typical signal sequence and a mature part of 396 amino acids. The protein contains 33 copies of the sequence Gly-Gly/Glu-(Ala-Pro)2-4-Ala-Glu. Using the single-letter code for the four predominant amino acids, we have termed this polypeptide the APEG protein. Near its carboxy-terminus, one segment has been found with an amino acid sequence similar to that of
spasmolytic polypeptide
from porcine pancreas and to the human protein
pS2
.
...
PMID:Dermal glands of Xenopus laevis contain a polypeptide with a highly repetitive amino acid sequence. 229 93
1
2
3
4
5
6
7
8
9
10
Next >>